2015
DOI: 10.1016/j.ijpharm.2015.02.015
|View full text |Cite
|
Sign up to set email alerts
|

Combined delivery of the adiponectin gene and rosiglitazone using cationic lipid emulsions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
4
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 21 publications
(27 reference statements)
0
4
0
Order By: Relevance
“…oil and water) can be achieved through emulsification methods, which are broadly classified as either high- or low-energy processes 2730 . Nanoscale emulsions with sizes on the order of 100 nm (so-called nanoemulsions) provide an efficient and facile approach to encapsulating both polar and non-polar functional biomolecules for co-delivery of dissimilar therapeutics 3133 . Multiple strategies have been employed to obtain thermogelling emulsion-based organohydrogels which are mostly based on entrapping the dispersed phase via thermally gelling the continuous phase 3437 .…”
Section: Introductionmentioning
confidence: 99%
“…oil and water) can be achieved through emulsification methods, which are broadly classified as either high- or low-energy processes 2730 . Nanoscale emulsions with sizes on the order of 100 nm (so-called nanoemulsions) provide an efficient and facile approach to encapsulating both polar and non-polar functional biomolecules for co-delivery of dissimilar therapeutics 3133 . Multiple strategies have been employed to obtain thermogelling emulsion-based organohydrogels which are mostly based on entrapping the dispersed phase via thermally gelling the continuous phase 3437 .…”
Section: Introductionmentioning
confidence: 99%
“…A promising approach for both studying and treating metabolic syndrome involves the use of a class of drugs called thiazolidinediones [1417], previously used to treat diabetes. Rosiglitazone (RGZ), the prototypical drug in this class, activates the nuclear peroxisome proliferator-activated receptor γ (PPARγ), a type II nuclear receptor, which in turn alters the expression of numerous genes [18], ultimately resulting in reduced blood concentrations of glucose, fatty acids, and insulin [19].…”
Section: Introductionmentioning
confidence: 99%
“…In considering these obstacles, non-viral gene carriers such as cationic polymers and lipids have been constructed based on their electrostatic interactions with DNA for gene delivery [21]. Cationic lipids, such as Lipofectamine [22,23] and 1,2-dioleoyl-3-trimethylammonium [24,25], are commonly used nonviral gene carriers owing to their high in vitro transfection efficiency. Furthermore, solid lipid nanoparticles can silence hepatitis C virus replication through delivering a shRNA targeted to internal ribosome entry site [26].…”
Section: Introductionmentioning
confidence: 99%